Replies to post #116 on Tibet Pharmaceuticals, Inc. (TBET)

[realfast95]

Both CSR and HRBN started out as non binding and it worked out.
And both traded 40-50% discount to the CEO offer until the it became clear the money was in place. Those were 400m where this one is close to 35m. The biggest risk IMO is that the committee will say it's too low because of the value of the assets.

I would agree, that one should have a portfolio with various risks.